[1] Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin，2021，71(3): 209-249. DOI: 10.3322/caac.21660.
[2] 柏树令, 应大君.系统解剖学[M].第9版.北京:人民卫生出版社, 2018: 315-321.
[3] 徐徕,钱易婍,肖毅.直肠癌术中保留神经的方法与注意事项[J].中国实用外科杂志,2017,37(6):683-685. DOI: 10.19538/j.cjps.issn1005-2208.2017.06.22.
[4] Zhu P, Lu T, Fan Z, et al. 5-hydroxytryptamine produced by enteric serotonergic neurons initiates colorectal cancer stem cell self-renewal and tumorigenesis[J]. Neuron, 2022, 110(14): 2268-2282.e4. DOI: 10.1016/j.neuron.2022.04.024.
[5] Folkman J. Tumor angiogenesis: therapeutic implications[J]. N Engl J Med,1971, 285(21):1182-1186. DOI:10.1056/NEJM1971111828 52108.
[6] Faulkner S, Jobling P, Hondermarck H, et al. Tumor Neurobiology and the War of Nerves in Cancer[J]. Cancer Discov, 2019, 9(6): 702-710. DOI: 10.1158/2159-8290.CD-18-1398.
[7] Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer[J]. Lancet Oncol, 2004, 5(10): 617-625. DOI: 10.1016/S1470-2045(04)01597-9.
[8] Lutgendorf SK, Sood AK. Biobehavioral factors and cancer progression: physiological pathways and mechanisms[J]. Psychosom Med, 2011, 73(9): 724-730. DOI: 10.1097/PSY.0b013e318235be76.
[9] Zahalka AH, Arnal-Estapé A, Frenette PS, et al. Adrenergic nerves activate an angio-metabolic switch in prostate cancer[J]. Science, 2017, 358(6361): 321-326. DOI: 10.1126/science.aah5072.
[10]Liu V, Dietrich A, Kreis ME, et al. Extrinsic intestinal denervation modulates tumor development in the small intestine of Apc(Min/+) mice[J]. J Exp Clin Cancer Res, 2015, 34(1):39. DOI: 10.1186/s13046-015-0159-0.
[11]Chin CC, Li JM, Shi CS, et al. Selective β2-AR Blockage Suppresses Colorectal Cancer Growth Through Regulation of EGFR-Akt/ERK1/2 Signaling, G1-Phase Arrest, and Apoptosis[J]. J Cell Physiol, 2016, 231(2): 459-472. DOI: 10.1002/jcp.25092.
[12]Mohammadpour H, MacDonald CR, Repasky EA, et al. β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells[J]. J Clin Invest, 2019,129(12): 5537-5552. DOI: 10.1172/JCI129502.
[13]Lin Y, Liu Y, Gao X, et al. Beta-adrenergic receptor blocker propranolol triggers anti-tumor immunity and enhances irinotecan therapy in mice colorectal cancer[J]. Eur J Pharmacol, 2023, 949: 175718. DOI: 10.1016/j.ejphar.2023.175718.
[14]Battaglin F, Jayachandran P, Lenz HJ, et al. Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment[J]. Oncogene, 2022, 41(43): 4769-4778. DOI: 10.1038/s41388-022-02479-4.
[15]Cheng K, Samimi R, Raufman JP, et al. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation[J]. Am J Physiol Gastrointest Liver Physiol, 2008, 295(3): G591-G597. DOI: 10.1152/ajpgi.00055.2008.
[16]Cheng K, Xie G, Raufman JP, et al. Divergent effects of muscarinic receptor subtype gene ablation on murine colon tumorigenesis reveals association of M3R and zinc finger protein 277 expression in colon neoplasia[J]. Mol Cancer, 2014,13: 77. DOI: 10.1186/1476-4598-13-77.
[17]Ali O, Tolaymat M, Raufman JP, et al. Overcoming Obstacles to Targeting Muscarinic Receptor Signaling in Colorectal Cancer[J]. Int J Mol Sci, 2021, 22(2). DOI: 10.3390/ijms22020716.
[18]Hoover DB. Cholinergic modulation of the immune system presents new approaches for treating inflammation[J]. Pharmacol Ther, 2017,179: 1-16. DOI: 10.1016/j.pharmthera.2017.05.002.
[19]Kuol N, Godlewski J, Nurgali K, et al. Cholinergic signaling influences the expression of immune checkpoint inhibitors, PD-L1 and PD-L2, and tumor hallmarks in human colorectal cancer tissues and cell lines[J]. BMC Cancer, 2023, 23(1): 971. DOI: 10.1186/s12885-023-11410-3.
[20]Wang H, Yu M, Tracey KJ, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation[J]. Nature, 2003, 421(6921): 384-388. DOI: 10.1038/nature01339.
[21] Partecke LI, Käding A, Keßler W, et al. Subdiaphragmatic vagotomy promotes tumor growth and reduces survival via TNFα in a murine pancreatic cancer model[J]. Oncotarget, 2017, 8(14): 22501-22512. DOI: 10.18632/oncotarget.15019.
[22]Dubeykovskaya Z, Si Y, Wang TC, et al. Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer[J]. Nat Commun, 2016, 7: 10517. DOI: 10.1038/ncomms10517.
[23]Lobbes LA, Schütze MA, Weixler B, et al. Muscarinic Acetylcholine Receptor M3 Expression and Survival in Human Colorectal Carcinoma-An Unexpected Correlation to Guide Future Treatment[J]. Int J Mol Sci, 2023, 24(9). DOI: 10.3390/ijms24098198.
[24]Hutchings C, Phillips JA, Djamgoz M. Nerve input to tumours: Pathophysiological consequences of a dynamic relationship[J]. Biochim Biophys Acta Rev Cancer, 2020, 1874(2): 188411. DOI: 10.1016/j.bbcan.2020.188411.
[25]Hanoun M, Maryanovich M, Frenette PS, et al. Neural regulation of hematopoiesis, inflammation, and cancer[J]. Neuron, 2015, 86(2): 360-373. DOI: 10.1016/j.neuron.2015.01.026.
[26]Schiweck C, Piette D Vrieze E, et al. Heart rate and high frequency heart rate variability during stress as biomarker for clinical depression. A systematic review[J]. Psychol Med, 2019, 49(2): 200-211. DOI: 10.1017/S0033291718001988.
[27]Mouton C, Ronson A, Gidron Y, et al. The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer[J]. Auton Neurosci, 2012, 166(1-2): 96-9. DOI: 10.1016/j.autneu.2011.10.002.
[28]Strous M, Daniels AM, Vogelaar FJ, et al. Is pre-operative heart rate variability a prognostic indicator for overall survival and cancer recurrence in patients with primary colorectal cancer[J]. PLoS One, 2020,15(8): e0237244. DOI: 10.1371/journal.pone.0237244.
[29]McGovern J, Leadbitter S, McMillan DC, et al. The relationship between heart rate variability and TNM stage, co-morbidity, systemic inflammation and survival in patients with primary operable colorectal cancer[J]. Sci Rep,2023,13(1): 8157.DOI: 10.1038/s41598-023-35396-x.
|
京ICP备08002354号-3
